[1] Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer MJ; Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis:proposed best practice recommendations for diagnosis and acute management[J]. J Neurol Neurosurg Psychiatry, 2021, 92:757-768. [2] Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol, 2016, 15:391-404. [3] Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma[J]. Ann Neurol, 2007, 61:25-36. [4] Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis[J]. Ann Neurol, 2018, 83:166-177. [5] van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, van Coevorden-Hameete MH, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Titulaer MJ. Anti-LGI1 encephalitis:clinical syndrome and long-term follow-up[J]. Neurology, 2016, 87:1449-1456. [6] Kaaden T, Madlener M, Angstwurm K, Bien CG, Bogarin Y, Doppler K, Finke A, Gerner ST, Reimann G, Häusler M, Handreka R, Hellwig K, Kaufmann M, Kellinghaus C, Koertvelyessy P, Kraft A, Lewerenz J, Menge T, Paliantonis A, von Podewils F, Prüss H, Rauer S, Ringelstein M, Rostásy K, Schirotzek I, Schwabe J, Sokolowski P, Suesse M, Sühs KW, Surges R, Tauber SC, Thaler F, Bergh FT, Urbanek C, Wandinger KP, Wildemann B, Mues S, Zettl U, Leypoldt F, Melzer N, Geis C, Malter M, Kunze A; the Generate study group. Seizure semiology in Antibody-associated autoimmune Encephalitis[J]. Neurol Neuroimmunol Neuroinflamm, 2022, 9:e200034. [7] Haberlandt E, Ensslen M, Gruber-Sedlmayr U, Plecko B, Brunner-Krainz M, Schimmel M, Schubert-Bast S, Neirich U, Philippi H, Kurleman G, Tardieu M, Wohlrab G, Borggraefe I, Rostásy K. Epileptic phenotypes, electroclinical features and clinical characteristics in 17 children with anti-NMDAR encephalitis[J]. Eur J Paediatr Neurol, 2017, 21:457-464. [8] Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush:a unique EEG pattern in adults with anti-NMDA receptor encephalitis[J]. Neurology, 2012, 79:1094-1100. [9] Neuroinfectious Diseases and Cerebrospinal Fluid Cytology Group, Neurology Branch, Chinese Medical Association. Expert consensus on diagnosis and treatment of autoimmune encephalitis in China (2022 edition)[J]. Zhonghua Shen Jing Ke Za Zhi, 2022, 55:931-949[.中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组. 中国自身免疫性脑炎诊治专家共识(2022年版)[J]. 中华神经科杂志, 2022, 55:931-949.] [10] Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM. ILAE classification of the epilepsies:position paper of the ILAE Commission for Classification and Terminology[J]. Epilepsia, 2017, 58:512-521. [11] Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshé SL, Peltola J, Roulet Perez E, Scheffer IE, Zuberi SM. Operational classification of seizure types by the International League Against Epilepsy:Position Paper of the ILAE Commission for Classification and Terminology[J]. Epilepsia, 2017, 58:522-530. [12] de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH, Bastiaansen AEM, Schreurs MWJ, Rouhl RPW, van Donselaar CA, Majoie MHJM, Neuteboom RF, Sillevis Smitt PAE, Thijs RD, Titulaer MJ. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis[J]. Neurology, 2019, 92:e2185-2196. [13] Qiao S, Wu HK, Liu LL, Zhang RR, Wang ML, Han T, Zhang SC, Liu XW. Characteristics and prognosis of autoimmune encephalitis in the east of China:a multi-center study[J]. Front Neurol, 2021, 12:642078. [14] Spatola M, Dalmau J. Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis[J]. Curr Opin Neurol, 2017, 30:345-353. [15] Muñoz-Lopetegi A, Graus F, Dalmau J, Santamaria J. Sleep disorders in autoimmune encephalitis[J]. Lancet Neurol, 2020, 19:1010-1022. [16] Yao L, Yue W, Xunyi W, Jianhong W, Guoxing Z, Zhen H. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis:a follow-up study in east China[J]. J Clin Neurosci, 2019, 68:73-79. [17] Zhang W, Wang X, Shao N, Ma R, Meng H. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis:a long-term study[J]. Epilepsy Behav, 2019, 94:198-203. [18] Moise AM, Karakis I, Herlopian A, Dhakar M, Hirsch LJ, Cotsonis G, LaRoche S, Cabrera Kang CM, Westover B, Rodriguez A. Continuous EEG findings in autoimmune encephalitis[J]. J Clin Neurophysiol, 2021, 38:124-129. [19] Yeshokumar AK, Coughlin A, Fastman J, Psaila K, Harmon M, Randell T, Schorr EM, Han H, Hoang H, Soudant C, Jette N. Seizures in autoimmune encephalitis:a systematic review and quantitative synthesis[J]. Epilepsia, 2021, 62:397-407. [20] Lascano AM, Vargas MI, Lalive PH. Diagnostic tools for immune causes of encephalitis[J]. Clin Microbiol Infect, 2019, 25:431-436. [21] Steriade C, Hantus S, Moosa ANV, Rae-Grant AD. Extreme delta-with or without brushes:a potential surrogate marker of disease activity in anti-NMDA-receptor encephalitis[J]. Clin Neurophysiol, 2018, 129:2197-2204. [22] Lin J, Li C, Li A, Liu X, Wang R, Chen C, Zhou D, Hong Z. Encephalitis with antibodies against the GABAB receptor:high mortality and risk factors[J]. Front Neurol, 2019, 10:1030. [23] Gillinder L, Britton J. Autoimmune-associated seizures[J]. Continuum (Minneap Minn), 2022, 28:363-398. |